Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulinastatin during open heart surgery: exhaled breath condensate and serum lung injury biomarkers
ChiCTR1800014299Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Nantong University
- Start
- Jan 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of ulinastatin in acute lung injury (ALI) (2 arms), sponsored by The Second Affiliated Hospital of Nantong University. Primary endpoints: Concentration of TNF-alpha, Concentration of interleukin-6 and 5 more. Planned start Jan 2018; status: not yet recruiting.
02
Drugs
ulinastatin
03
Conditions
acute lung injury (ALI)
Beyond the preview
Go deeper on ChiCTR1800014299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014299.